Plasma‐Activated Solutions Mitigates DSS‐Induced Colitis via Restoring Redox Homeostasis and Reversing Microbiota Dysbiosis
Advanced Science · 2023
DOI: 10.1002/advs.202304044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2023. Verfasst von Tuanhe Sun und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Colitis, Microbiota. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ulcerative colitis is a chronic disease that increases the risk of developing colorectal cancer. Conventional medications are limited by drug delivery and a weak capacity to modulate the inflammatory microenvironment. Further, gut microbiota dysbiosis caused by mucosal damage and dysregulated redox homeostasis leads to frequent recurrence. Therefore, promoting mucosal healing and restoring redox homeostasis is considered the initial step in treating ulcerative colitis. Plasma‐activated solutions (PAS) are liquids rich in various reactive nitrogen species (RNS) and reactive oxygen species (ROS) and are used to treat multiple diseases. However, its effect on ulcerative colitis remains to be examined. Therefore, using a DSS‐induced mice colitis model, it is found that PAS has the potential to treat colitis and prevent its recurrence by promoting intestinal mucosal repair, reducing inflammation, improving redox homeostasis, and reversing gut microbiota dysbiosis. Further, an equipment is designed for preparing PAS without using nitrogen; however, after treatment with the Nitro‐free PAS, the therapeutic effect of PAS is significantly weakened or even lost, indicating that RNS may be the main mediator by which PAS exerts its therapeutic effects. Overall, this study demonstrates the treatment of ulcerative colitis as a novel application of PAS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China.
- State Key Laboratory of Electrical Insulation and Power Equipment, School of Electrical Engineering, Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China.
- Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China.
- Department of Nuclear Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China.
ORCID-Profile: Tuanhe Sun, Guanjun Zhang, Hao Zhang
Zitieren
APA
Sun, T., Ren, K., Xu, G., Ma, R., Wang, X., Min, T., Xie, X., Sun, A., Ma, Y., Wang, H., Zhang, Y., Zhu, K., Dang, C., Zhang, G., & Zhang, H. (2023). Plasma‐Activated Solutions Mitigates DSS‐Induced Colitis via Restoring Redox Homeostasis and Reversing Microbiota Dysbiosis. Advanced Science. https://doi.org/10.1002/advs.202304044
Vancouver
Sun T, Ren K, Xu G, Ma R, Wang X, Min T, et al. Plasma‐Activated Solutions Mitigates DSS‐Induced Colitis via Restoring Redox Homeostasis and Reversing Microbiota Dysbiosis. Advanced Science. 2023. doi:10.1002/advs.202304044
BibTeX
@article{Sun2023,
author = {Sun, Tuanhe and Ren, Kaijie and Xu, Guimin and Ma, Rulan and Wang, Xueni and Min, Tianhao and Xie, Xin and Sun, Anbang and Ma, Yuyi and Wang, Haonan and Zhang, Yong and Zhu, Kun and Dang, Chengxue and Zhang, Guanjun and Zhang, Hao},
title = {Plasma‐Activated Solutions Mitigates DSS‐Induced Colitis via Restoring Redox Homeostasis and Reversing Microbiota Dysbiosis},
journal = {Advanced Science},
year = {2023},
doi = {10.1002/advs.202304044}
}
EUVIMED